PROTAC targeted protein degraders: the past is prologueMiklós Békés, Craig M. Crews|Nature Reviews Drug Discovery|2022Cited by 2.9k
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligaseBlake E. Smith, Craig M. Crews|Nature Communications|2019Cited by 516
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistanceJemilat Salami, Craig M. Crews|Communications Biology|2018Cited by 343
Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACsPatrick Pfaff, Erick M. Carreira, Kusal T. G. Samarasinghe et al.|ACS Central Science|2019Cited by 287
Targeted Protein Degradation by Small MoleculesDaniel P. Bondeson, Craig M. Crews|The Annual Review of Pharmacology and Toxicology|2016Cited by 203